351325-31-0 Usage
Uses
Used in Pharmaceutical Industry:
5-Bromo-2,4-difluoro-benzoic acid methyl ester serves as a crucial intermediate in the synthesis of a variety of drugs and biologically active compounds. Its unique structure allows for the development of new pharmaceutical agents with potential therapeutic applications.
Used in Agrochemical Production:
5-BroMo-2,4-difluoro-benzoic acid Methyl ester also finds application in the production of agrochemicals, where it can be utilized as a building block for the creation of pesticides and other agricultural chemicals, contributing to enhanced crop protection and yield.
Used in Specialty Chemicals:
5-Bromo-2,4-difluoro-benzoic acid methyl ester is employed in the synthesis of specialty chemicals, which are often used in specific industries for their unique properties. Its versatility in chemical reactions makes it a valuable precursor for the development of tailored chemical products.
Check Digit Verification of cas no
The CAS Registry Mumber 351325-31-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,1,3,2 and 5 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 351325-31:
(8*3)+(7*5)+(6*1)+(5*3)+(4*2)+(3*5)+(2*3)+(1*1)=110
110 % 10 = 0
So 351325-31-0 is a valid CAS Registry Number.
351325-31-0Relevant articles and documents
BROMODOMAIN INHIBITORS
-
Paragraph 00387, (2017/11/10)
The present invention provides for compounds of formula (I) wherein R1, R2, R3, R4, R6, X1, and X2 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising compounds of formula (I).
CHEMICAL COMPOUNDS
-
Page/Page column 66-67, (2012/02/02)
The invention relates to sulfonamide derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to a new sulfonamide Nav1.7 inhibitors of formula 10 (I): (I) or a pharmaceutically acceptable salt thereof, wherein Z, R 1, R2, R3, R4 and R5 are as defined in the description. Nav 1.7 inhibitors are potentially useful in the treatment of a wide range of disorders, particularly pain.
